These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28561706)

  • 1. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
    Penas-Prado M
    Am Soc Clin Oncol Educ Book; 2017; 37():187-191. PubMed ID: 28561706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of recently described genetic alterations in central nervous system tumors.
    Lucas CG; Solomon DA; Perry A
    Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization 2016 Classification of Central Nervous System Tumors.
    Diamandis P; Aldape K
    Neurol Clin; 2018 Aug; 36(3):439-447. PubMed ID: 30072064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system.
    Komori T
    Brain Tumor Pathol; 2021 Jan; 38(1):1-3. PubMed ID: 33398472
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO 2016 Classification of gliomas.
    Wesseling P; Capper D
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
    Malzkorn B; Reifenberger G
    Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
    Brat DJ; Aldape K; Colman H; Holland EC; Louis DN; Jenkins RB; Kleinschmidt-DeMasters BK; Perry A; Reifenberger G; Stupp R; von Deimling A; Weller M
    Acta Neuropathol; 2018 Nov; 136(5):805-810. PubMed ID: 30259105
    [No Abstract]   [Full Text] [Related]  

  • 15. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
    Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
    Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
    Aldape K; Nejad R; Louis DN; Zadeh G
    Neuro Oncol; 2017 Mar; 19(3):336-344. PubMed ID: 27688263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
    Whitfield BT; Huse JT
    Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
    Pinheiro JAF; de Almeida JCM; Lopes JMPB
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated 2016 WHO classification of tumors of the CNS: turning the corner where molecule meets pathology.
    Komori T
    Brain Tumor Pathol; 2017 Oct; 34(4):139-140. PubMed ID: 28840403
    [No Abstract]   [Full Text] [Related]  

  • 20. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
    Macaulay RJ
    Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.